Today: 11 June 2026
Lam Research (LRCX) stock holds up after Taiwan tool order, Needham target hike as markets slide
20 January 2026
1 min read

Lam Research (LRCX) stock holds up after Taiwan tool order, Needham target hike as markets slide

New York, January 20, 2026, 11:23 (EST) — Regular session

  • Lam Research holds firm following Winbond’s announcement of a T$6.81 billion equipment order from a Lam subsidiary
  • Needham raises its price target for Lam Research to $250
  • Traders are eyeing Lam’s Jan. 28 earnings for new clues on chip-factory spending trends

Lam Research shares held steady Tuesday following Taiwan’s Winbond Electronics announcement that it will purchase machinery equipment from Lam Research International worth T$6.81 billion ($215.66 million). Needham also bumped its price target up sharply, from $160 to $250.

Timing is crucial. Since the start of the year, chip-equipment shares have been volatile, with investors eager for clear signs on whether factory spending is genuinely rising or merely accelerating orders ahead of schedule.

These firms operate near the start of the supply chain. “Wafer fab equipment” refers to the machines used to produce chips in factories, and their orders often fluctuate with customer capital expenditure plans and shifts in policy.

By 11:08 a.m. EST, Lam Research was barely changed, edging up 0.02% to $223.01, bouncing between a low of $215.00 and a high near $226.08. Applied Materials slipped 2.5%, while KLA dipped 2.7% during that same stretch.

The broader market weighed on it. Wall Street dropped to its lowest point in nearly three weeks after President Donald Trump threatened new tariffs on multiple European nations amid a Greenland dispute. A strategist noted the market was reacting sharply to the headlines.

The Winbond deal provides another signal of Asia-driven demand. Traders often treat these reported tool purchases as a quick snapshot of build activity, particularly in memory and specialty chips, where spending can shift rapidly.

Needham’s boost to its target price pushed Lam back among the “held up better than peers” group amid a tough session for semicap stocks. The new target hangs significantly above Tuesday’s trading levels.

The group bounced back last week following Taiwan Semiconductor Manufacturing Co’s earnings and capital expenditure forecast, which boosted confidence in chip-factory investments.

The setup remains messy. One big order won’t necessarily spark momentum, and any tariff fight flare-ups could unsettle high-multiple tech stocks and hold back customer spending.

Lam’s quarterly earnings call is scheduled for Jan. 28. Investors will be digging for details on demand trends, customer spending patterns, and whether order volumes are steady heading into the next quarter.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Grab stock rises even as Wall Street slides after BofA upgrade — what’s next for GRAB
Previous Story

Grab stock rises even as Wall Street slides after BofA upgrade — what’s next for GRAB

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps
Next Story

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps

Go toTop